Clinical Trial Update: A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 study of atezolizumab plus carboplatin and etoposide with or without tiragolumab in untreated extensive-stage small cell lung cancer has completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-10-22